Sanofi (SNY) News Today $51.68 +0.82 (+1.61%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$51.21 -0.47 (-0.91%) As of 05/16/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Sanofi Up Today?Sanofi (NASDAQ:SNY) is seeing its stock trade higher today amid a flurry of institutional buying and upbeat analyst commentary. Institutional inflows: Point72 Asset Management boosted its Sanofi stake by 969.6%, Quantinno Capital added 68,444 shares (+69.2%), Pathstone Holdings increased by 22.5%, Nuveen Asset Management added 34,660 shares, Focus Partners Wealth lifted its position by 8.8%, Parkwood LLC bought 33,342 shares (+15%), Ameriprise Financial grew its stake by 23.4%, Jane Street Group jumped in by 1,210%, and BNP Paribas raised its holding by 67.5%. Some trimming: Sphera Funds cut its stake by 6.1%, Janus Henderson sold 19,162 shares (–2.2%), and Captrust Financial Advisors reduced its position by 21.3%. Analyst updates: Zacks Research raised its Q2 2025 EPS estimate to $0.95, while Bank of America Securities reiterated a Buy rating on the back of Sanofi’s promising pipeline and perceived undervaluation. Separately, Zacks trimmed its Q3 2026 EPS forecast slightly to $1.34. Corporate strategy: Sanofi’s plan to invest at least $20 billion in the U.S. through 2030 has drawn criticism from France’s finance minister, but underscores the company’s long-term growth focus. Overall, the sizable net purchases by hedge funds and asset managers, alongside positive earnings revisions, are underpinning today’s upward momentum in Sanofi shares.Posted 11h agoAI generated SNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Sanofi (NASDAQ:SNY) Shares Bought by Parkwood LLCParkwood LLC grew its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 15.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 255,717 shares of the company's stock after purchasing an addiMay 16 at 8:11 AM | marketbeat.comSanofi’s Promising Pipeline and Undervaluation Support Buy RatingMay 16 at 7:06 AM | tipranks.comJanus Henderson Group PLC Sells 19,162 Shares of Sanofi (NASDAQ:SNY)Janus Henderson Group PLC reduced its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 2.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 862,520 shares of the company's stock after selling 19,162 shares during the period. Janus Henderson Group PLMay 16 at 5:06 AM | marketbeat.comSanofi to invest at least $20B in U.S. through 2030May 15 at 4:36 PM | msn.comFrench finance minister criticises Sanofi's $20 bln USA investment decisionMay 15 at 12:55 PM | reuters.comCaptrust Financial Advisors Has $1.83 Million Stake in Sanofi (NASDAQ:SNY)Captrust Financial Advisors trimmed its holdings in Sanofi (NASDAQ:SNY - Free Report) by 21.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,027 shares of the company's stock afterMay 15 at 4:14 AM | marketbeat.comBNP Paribas Financial Markets Has $5.87 Million Holdings in Sanofi (NASDAQ:SNY)BNP Paribas Financial Markets lifted its position in Sanofi (NASDAQ:SNY - Free Report) by 67.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 121,613 shares of the company's stock aMay 15 at 3:55 AM | marketbeat.comAmeriprise Financial Inc. Boosts Stock Position in Sanofi (NASDAQ:SNY)Ameriprise Financial Inc. grew its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 23.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 810,602 shares of the company's stockMay 15 at 3:53 AM | marketbeat.comJane Street Group LLC Increases Stake in Sanofi (NASDAQ:SNY)Jane Street Group LLC boosted its stake in Sanofi (NASDAQ:SNY - Free Report) by 1,210.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 69,475 shares of the company's stock after purchasing an additional 64,173 sharesMay 15 at 3:45 AM | marketbeat.comSanofi (SNY): A Bull Case TheoryMay 14 at 7:32 PM | finance.yahoo.comSanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030May 14 at 4:31 PM | benzinga.comSanofi (SNY) Commits $20 Billion U.S. Investment by 2030May 14 at 2:40 PM | gurufocus.comSanofi to invest at least $20 billion in the US through 2030May 14 at 1:29 PM | reuters.comSanofi to invest at least $20 billion in the US through 2030May 14 at 1:29 PM | reuters.comSanofi will invest at least $20B in the U.S., focus on R&D spendsMay 14 at 1:16 PM | msn.comSanofi (SNY) Plans $20 Billion US Investment by 2030 to Boost R&D and Manufacturing | SNY ...May 14 at 1:04 PM | gurufocus.comSanofi to invest at least $20 billion in the US through 2030, growing investments in science ...May 14 at 1:04 PM | gurufocus.comSanofi to invest at least $20 billion in the US through 2030, growing investments in science ...May 14 at 1:04 PM | gurufocus.comSanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturingMay 14 at 12:30 PM | prnewswire.comCetera Investment Advisers Grows Stock Position in Sanofi (NASDAQ:SNY)Cetera Investment Advisers lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 199,138 shares of the company's stock after purchasing an additionalMay 14 at 4:39 AM | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by Balyasny Asset Management L.P.Balyasny Asset Management L.P. cut its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 89.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 71,094 shares of the company's stock after selling 600,655 shares durMay 14 at 4:21 AM | marketbeat.comSanofi (SNY): A Bull Case TheoryMay 13, 2025 | insidermonkey.comCrestline Management LP Acquires New Holdings in Sanofi (NASDAQ:SNY)Crestline Management LP bought a new position in shares of Sanofi (NASDAQ:SNY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 7,121 shares of the company's stock, valued at approximatelyMay 13, 2025 | marketbeat.comDimensional Fund Advisors LP Has $7.94 Million Position in Sanofi (NASDAQ:SNY)Dimensional Fund Advisors LP grew its holdings in Sanofi (NASDAQ:SNY - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 164,538 shares of the company's stock after buying an additional 5,198 shares durMay 13, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives $63.33 Consensus Target Price from AnalystsMay 13, 2025 | americanbankingnews.comSanofi (NASDAQ:SNY) Given Consensus Recommendation of "Buy" by BrokeragesShares of Sanofi (NASDAQ:SNY - Get Free Report) have been assigned an average rating of "Buy" from the seven analysts that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and three have issuedMay 12, 2025 | marketbeat.comEthic Inc. Acquires 22,001 Shares of Sanofi (NASDAQ:SNY)Ethic Inc. lifted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 26.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 105,127 shares of the company's stock after acquiring an additional 22,001 sharesMay 12, 2025 | marketbeat.comHawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning labelMay 9, 2025 | reuters.comBrown Advisory Inc. Has $11.58 Million Stake in Sanofi (NASDAQ:SNY)Brown Advisory Inc. increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 82.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 240,053 shares of the company's stock afterMay 9, 2025 | marketbeat.comNovavax rises after massive Q1 beat, guidance raiseMay 8, 2025 | msn.comBank of America Corp DE Has $579.59 Million Position in Sanofi (NASDAQ:SNY)Bank of America Corp DE raised its holdings in Sanofi (NASDAQ:SNY - Free Report) by 3.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,017,140 shares of the company's stock after purchasing an additional 441,637 shareMay 8, 2025 | marketbeat.com38,883 Shares in Sanofi (NASDAQ:SNY) Acquired by Bayesian Capital Management LPBayesian Capital Management LP bought a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 38,883 shares of the company's stock, valued at approximately $1,875,000. SeveMay 7, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Purchases 5,532 Shares of Sanofi (NASDAQ:SNY)Mercer Global Advisors Inc. ADV raised its holdings in Sanofi (NASDAQ:SNY - Free Report) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 123,689 shares of the company's stock after purchasing aMay 7, 2025 | marketbeat.comNorthern Trust Corp Has $93.11 Million Stake in Sanofi (NASDAQ:SNY)Northern Trust Corp raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 44.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,930,560 shares of the company's stock after acquiring an additional 597,959 shares durMay 7, 2025 | marketbeat.comSanofi’s credit rating upgraded to Aa3 by Moody’s RatingsMay 6, 2025 | investing.comSanofi: Investing in prevention builds Europe's health and competitivenessMay 6, 2025 | globenewswire.comAlyeska Investment Group L.P. Sells 1,777,833 Shares of Sanofi (NASDAQ:SNY)Alyeska Investment Group L.P. lowered its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 63.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,002,632 shares of the company's stock after selling 1,777,833 shMay 6, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Raises Position in Sanofi (NASDAQ:SNY)The Manufacturers Life Insurance Company boosted its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 122.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 356,058 shares of the compMay 6, 2025 | marketbeat.comSanofi Approves 2024 Financials and Announces Dividend at AGMMay 5, 2025 | tipranks.comHsbc Holdings PLC Boosts Stock Holdings in Sanofi (NASDAQ:SNY)Hsbc Holdings PLC lifted its stake in Sanofi (NASDAQ:SNY - Free Report) by 258.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,033 shares of the company's stock after purchasing an additional 25,263 sharMay 4, 2025 | marketbeat.comSanofi Consumer Healthcare India Releases Q1 2025 Financial ResultsMay 3, 2025 | tipranks.comSanofi (NASDAQ:SNY) Upgraded at Hsbc Global ResHsbc Global Res raised shares of Sanofi to a "strong-buy" rating in a report on Monday.May 3, 2025 | marketbeat.comKovitz Investment Group Partners LLC Has $769,000 Stock Holdings in Sanofi (NASDAQ:SNY)Kovitz Investment Group Partners LLC decreased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 73.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,938 shares of the compaMay 3, 2025 | marketbeat.comSanofi (SNY, Financials) Completes Opella Deal, Creates Consumer Health LeaderMay 2, 2025 | finance.yahoo.comSanofi (NASDAQ:SNY) Shares Sold by Becker Capital Management Inc.Becker Capital Management Inc. decreased its position in Sanofi (NASDAQ:SNY - Free Report) by 5.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 553,764 shares of the company's stock after selling 30,578 shares during the period. Becker Capital ManagemMay 2, 2025 | marketbeat.comRegal Partners Ltd Takes Position in Sanofi (NASDAQ:SNY)Regal Partners Ltd bought a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 726,385 shares of the company's stock, valued at approximately $35,0May 2, 2025 | marketbeat.comSoros Fund Management LLC Sells 200,000 Shares of Sanofi (NASDAQ:SNY)Soros Fund Management LLC reduced its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 50.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 200,000 shares of the company's stock after sellMay 1, 2025 | marketbeat.comSanofi Completes Opella Transaction, Shifts Focus to BiopharmaApril 30, 2025 | tipranks.comPress Release: Annual General Meeting of April 30, 2025April 30, 2025 | globenewswire.comSanofi (SNY) Finalizes Opella Stake Sale for EUR 10 Billion | SNY Stock NewsApril 30, 2025 | gurufocus.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼1.060.79▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼3115▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News NVS News AZN News GSK News TAK News ARGX News BNTX News ONC News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
